Lack of inflammatory bowel disease flare-up following two-dose BNT162b2 vaccine: a population-based cohort study

We read with interest the recent paper by Cannatelli et al1 describing the adverse events (AEs) following COVID-19 vaccination from a large inflammatory bowel disease (IBD) cohort, which showed that patients with IBD had a similar rate of reported AEs to the general population but with a slightly hi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gut 2022-12, Vol.71 (12), p.2608-2611
Hauptverfasser:	Li, Xue, Tong, Xinning, Wong, Ian Chi Kei, Peng, Kuan, Chui, Celine Sze Ling, Lai, Francisco Tsz Tsun, Wan, Eric Yuk Fai, Wong, Carlos King Ho, Leung, Wai Keung, Chan, Esther Wai Yin
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological products Chronic illnesses Confidence intervals Coronaviruses COVID-19 COVID-19 vaccines Crohn's disease Drug dosages Electronic medical records Emergency medical care epidemiology Hospitalization Hospitals Immunization Immunosuppressive agents Immunotherapy Inflammatory bowel disease Inflammatory bowel diseases Intestine Liver diseases Population studies PostScript Severe acute respiratory syndrome coronavirus 2 Vaccination Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!